Muscleblind-like splicing regulator 1 (MBNL1), one of the members of the MBNL protein family, has been negatively correlated with poor prognosis in breast, lung, and gastric cancers, and inhibits the recurrence and metastasis of triple-negative breast cancer [13]. This evidence concerns the gene MBNL1 and triple-negative breast carcinoma.